eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Guidance for Industry; Availability: Clinical Pharmacogenomics; Premarket Evaluation in Early-Phase Clinical Studies and Recommendations for Labeling

Guidance for Industry; Availability: Clinical Pharmacogenomics; Premarket Evaluation in Early-Phase Clinical Studies and Recommendations for Labeling

Document ID: FDA-2011-D-0082-0021
Document Type: Notice
Agency: Food And Drug Administration
Topics: No Topics associated with this document
Federal Register Number: 2013-01638
View Document:  View as format pdf View as format html

Details Information

Document Subtype: Notice of Availability
Received Date: January 25 2013, at 12:00 AM Eastern Standard Time
Start-End Page: 5816 - 5817
Page Count: 2
Comment Start Date: January 28 2013, at 12:00 AM Eastern Standard Time

Comments

Total: 0
No comments posted.

Related Documents

Total: 0
No documents available.